Home
About
Services
Partners
Client Portfolio
News
Contact
Apple reports higher sales as China reopens after coronavirus but gives no forecast
April 30, 2020
Amazon’s second-quarter forecast weighed down by $4 billion in COVID-19 related costs, shares fall
April 30, 2020
0
Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results
Published by
Muller&Green
at
April 30, 2020
Categories
RSS
Tags
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more